JP2022523548A5 - - Google Patents
Info
- Publication number
- JP2022523548A5 JP2022523548A5 JP2021552571A JP2021552571A JP2022523548A5 JP 2022523548 A5 JP2022523548 A5 JP 2022523548A5 JP 2021552571 A JP2021552571 A JP 2021552571A JP 2021552571 A JP2021552571 A JP 2021552571A JP 2022523548 A5 JP2022523548 A5 JP 2022523548A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- therapeutic agent
- weight
- biodegradable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024176400A JP7852008B2 (ja) | 2019-03-05 | 2024-10-08 | 眼の疾患又は障害を治療するための医薬組成物 |
| JP2024176401A JP7838047B2 (ja) | 2019-03-05 | 2024-10-08 | 眼の疾患又は障害を治療するための医薬組成物 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962814198P | 2019-03-05 | 2019-03-05 | |
| US62/814,198 | 2019-03-05 | ||
| PCT/US2020/021136 WO2020181060A1 (en) | 2019-03-05 | 2020-03-05 | Pharmaceutical compositions for treating ocular diseases or disorders |
Related Child Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024176401A Division JP7838047B2 (ja) | 2019-03-05 | 2024-10-08 | 眼の疾患又は障害を治療するための医薬組成物 |
| JP2024176400A Division JP7852008B2 (ja) | 2019-03-05 | 2024-10-08 | 眼の疾患又は障害を治療するための医薬組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022523548A JP2022523548A (ja) | 2022-04-25 |
| JP2022523548A5 true JP2022523548A5 (enExample) | 2023-03-08 |
| JP7570342B2 JP7570342B2 (ja) | 2024-10-21 |
Family
ID=72337143
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021552571A Active JP7570342B2 (ja) | 2019-03-05 | 2020-03-05 | 眼の疾患又は障害を治療するための医薬組成物 |
| JP2024176400A Active JP7852008B2 (ja) | 2019-03-05 | 2024-10-08 | 眼の疾患又は障害を治療するための医薬組成物 |
| JP2024176401A Active JP7838047B2 (ja) | 2019-03-05 | 2024-10-08 | 眼の疾患又は障害を治療するための医薬組成物 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024176400A Active JP7852008B2 (ja) | 2019-03-05 | 2024-10-08 | 眼の疾患又は障害を治療するための医薬組成物 |
| JP2024176401A Active JP7838047B2 (ja) | 2019-03-05 | 2024-10-08 | 眼の疾患又は障害を治療するための医薬組成物 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US12478577B2 (enExample) |
| EP (1) | EP3934646A4 (enExample) |
| JP (3) | JP7570342B2 (enExample) |
| KR (1) | KR20210135560A (enExample) |
| CN (3) | CN118304422A (enExample) |
| AU (1) | AU2020232314C1 (enExample) |
| BR (1) | BR112021017436A2 (enExample) |
| CA (1) | CA3132635A1 (enExample) |
| MX (2) | MX2021010599A (enExample) |
| WO (1) | WO2020181060A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20210135560A (ko) | 2019-03-05 | 2021-11-15 | 에어리 파마슈티컬즈, 인코포레이티드 | 안구 질환 또는 장애를 치료하는 약학 조성물 |
| PT3861985T (pt) | 2020-02-06 | 2023-08-03 | Ocular Therapeutix Inc | Composições e métodos para tratar doenças oculares |
| PT3884929T (pt) | 2020-03-25 | 2023-08-09 | Ocular Therapeutix Inc | Implante ocular contendo um inibidor da tirosina cinase |
| US20230149387A1 (en) * | 2020-04-08 | 2023-05-18 | Aerie Pharmaceuticals, Inc. | Treatments |
| EP4329753A4 (en) | 2021-04-30 | 2025-02-26 | Perfuse Therapeutics, Inc. | PHARMACEUTICAL COMPOSITIONS AND INTRAVITREAL DRUG DELIVERY SYSTEMS FOR THE TREATMENT OF EYE DISEASES |
| US20240239750A1 (en) | 2021-05-05 | 2024-07-18 | Aerie Pharmaceuticals, Inc. | Pharmaceutical preparation |
| PE20260040A1 (es) | 2023-04-11 | 2026-01-09 | Ocular Therapeutix Inc | Implante ocular que contiene un inhibidor de la tirosina cinasa |
| WO2025146683A1 (en) | 2024-01-03 | 2025-07-10 | Lyotropic Delivery Systems Ltd. | Topical formulations for delivery of an active compound to the back of the eye |
| WO2025169089A1 (en) | 2024-02-05 | 2025-08-14 | Sun Pharmaceutical Industries Limited | Ophthalmic compositions of tyrosine kinase inhibitors and their uses |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2649672C (en) * | 2006-05-02 | 2015-07-07 | Medivas, Llc | Delivery of ophthalmologic agents to the exterior or interior of the eye |
| US20110158910A1 (en) | 2008-04-25 | 2011-06-30 | Aylvin Jorge Angelo Athanasius Dias | Microparticles comprising polymers with thioester bonds |
| US9095506B2 (en) | 2008-11-17 | 2015-08-04 | Allergan, Inc. | Biodegradable alpha-2 agonist polymeric implants and therapeutic uses thereof |
| CN110187549B (zh) * | 2010-06-22 | 2022-07-15 | 东洋纺株式会社 | 液晶显示装置、偏振板及偏振片保护膜 |
| BR112013018739A2 (pt) * | 2010-12-29 | 2019-09-24 | Jade Therapeutics Inc | sistema de distribuição de medicamento ocular |
| EP2704748B1 (en) * | 2011-05-02 | 2018-08-15 | DSM IP Assets B.V. | Bis-(alpha-amino-diol-diester) containing polyesteramide for ophtamology |
| JP6135870B2 (ja) * | 2011-05-02 | 2017-05-31 | ディーエスエム アイピー アセッツ ビー．ブイ． | 生分解性ポリマーを含む繊維 |
| WO2013126799A1 (en) * | 2012-02-22 | 2013-08-29 | Trustees Of Tufts College | Compositions and methods for ocular delivery of a therapeutic agent |
| CN104717962B (zh) * | 2012-10-02 | 2017-07-21 | 帝斯曼知识产权资产管理有限公司 | 包含蛋白质和可生物降解聚酯酰胺的药物递送组合物 |
| EP3702394B1 (en) | 2012-10-24 | 2023-11-22 | DSM IP Assets B.V. | Fibers comprising polyesteramide copolymers for drug delivery |
| EP2956096A1 (en) * | 2013-02-15 | 2015-12-23 | Allergan, Inc. | Sustained drug delivery implant |
| AU2014248460B2 (en) | 2013-04-01 | 2019-04-11 | Allergan, Inc. | Microsphere drug delivery system for sustained intraocular release |
| WO2015126477A1 (en) | 2013-11-08 | 2015-08-27 | Tyrx, Inc. | Polymeric drug delivery system for treating surgical complications |
| US20160296627A1 (en) * | 2013-12-06 | 2016-10-13 | Envisia Therapeutics Inc. | Intracameral implant for treatment of an ocular condition |
| CA2933900A1 (en) | 2013-12-20 | 2015-06-25 | Georgia Tech Research Corporation | Formulations and methods for targeted ocular delivery of therapeutic agents |
| US9931306B2 (en) | 2014-09-06 | 2018-04-03 | Integral Biosystems Llc | Methods and biocompatible compositions to achieve sustained drug release in the eye |
| US10434071B2 (en) | 2014-12-18 | 2019-10-08 | Dsm Ip Assets, B.V. | Drug delivery system for delivery of acid sensitivity drugs |
| CN108883070A (zh) | 2015-07-23 | 2018-11-23 | 爱瑞制药公司 | 用于治疗眼病的玻璃体内药物递送系统 |
| WO2017120600A1 (en) | 2016-01-08 | 2017-07-13 | Clearside Biomedical, Inc. | Compositions and methods of treating wet age-related macular degeneration |
| US20180117148A1 (en) * | 2016-10-28 | 2018-05-03 | Andrew J. Holman | Compounds, pharmaceutical compositions and methods of treatments of immune related diseases and disorders |
| AU2018226872A1 (en) | 2017-03-03 | 2019-09-05 | Macregen, Inc. | Treatment of age-related macular degeneration and other eye diseases with one or more therapeutic agents |
| KR20210135560A (ko) | 2019-03-05 | 2021-11-15 | 에어리 파마슈티컬즈, 인코포레이티드 | 안구 질환 또는 장애를 치료하는 약학 조성물 |
-
2020
- 2020-03-05 KR KR1020217031760A patent/KR20210135560A/ko active Pending
- 2020-03-05 CA CA3132635A patent/CA3132635A1/en active Pending
- 2020-03-05 CN CN202410368231.1A patent/CN118304422A/zh active Pending
- 2020-03-05 CN CN202410368463.7A patent/CN118286445A/zh active Pending
- 2020-03-05 AU AU2020232314A patent/AU2020232314C1/en active Active
- 2020-03-05 WO PCT/US2020/021136 patent/WO2020181060A1/en not_active Ceased
- 2020-03-05 CN CN202080033265.5A patent/CN113784727B/zh active Active
- 2020-03-05 JP JP2021552571A patent/JP7570342B2/ja active Active
- 2020-03-05 EP EP20766052.3A patent/EP3934646A4/en active Pending
- 2020-03-05 BR BR112021017436A patent/BR112021017436A2/pt unknown
- 2020-03-05 US US16/810,149 patent/US12478577B2/en active Active
- 2020-03-05 MX MX2021010599A patent/MX2021010599A/es unknown
-
2021
- 2021-09-02 MX MX2025002265A patent/MX2025002265A/es unknown
-
2024
- 2024-10-08 JP JP2024176400A patent/JP7852008B2/ja active Active
- 2024-10-08 JP JP2024176401A patent/JP7838047B2/ja active Active
-
2025
- 2025-10-10 US US19/355,788 patent/US20260034056A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022523548A5 (enExample) | ||
| AU2007248143B2 (en) | A sustained-release intraocular implant comprising a vasoactive agent | |
| AU2011284589B2 (en) | Compounds for the treatment/prevention of ocular inflammatory diseases | |
| CA2653902C (en) | Use of a steroid prodrug for the treatment of disease of the posterior segment of the eye | |
| CN104185472B (zh) | 4‑孕甾烯‑11β‑17‑21‑三醇‑3，20‑二酮衍生物的药物组合物和使用方法 | |
| BR112012018134B1 (pt) | Uso de um agente terapêutico e implante de liberação sustentada biodegradável para tratar uma condição ocular | |
| BRPI0613401B1 (pt) | Composição oftálmica compreendendo derivados de glicocorticoides que penetram seletivamente nos tecidos do segmento posterior | |
| JP2020121985A5 (enExample) | ||
| US20060148686A1 (en) | Ophthalmic compositions comprising steroid and cyclosporine for dry eye therapy | |
| JP2015506983A5 (enExample) | ||
| JP2018521126A (ja) | 眼炎症状態を処置する際に使用するための、インテグリンα４アンタゴニストを含む薬学的組成物 | |
| US20060154910A1 (en) | Use of steroids to treat ocular disorders | |
| JP2019524679A5 (enExample) | ||
| JP7571037B2 (ja) | 眼表面疼痛を治療する方法 | |
| US10350223B2 (en) | Compositions and methods for treating ocular diseases | |
| CN100431544C (zh) | 用于治疗病理性眼血管生成的糖皮质激素制剂 | |
| JP2016050181A (ja) | 血管炎治療剤 | |
| US20250387410A1 (en) | Treatment of anti-vegf refractory ophthalmic retinal eye conditions | |
| US20090181933A1 (en) | Use of steroids to treat persons suffering from ocular disorders | |
| JP2025507416A5 (enExample) | ||
| WO2005102297A2 (en) | Angiostatic agents for controlling choroidal neovascularisation after ocular surgery of trauma | |
| Misra et al. | Comparative evaluation of the antiinflammatory effect of topical 0.1% dexamethasone sodium and topical 1% prednisolone acetate eye drops after small incision cataract surgery in Indian eyes | |
| PT2319517E (pt) | Utilização de pró-fármacos para administração ocular por via intra-vítrea | |
| JP2006290880A (ja) | 感覚神経の異常改善剤 |